Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.20p
   
  • Change Today:
      0.050p
  • 52 Week High: 14.25p
  • 52 Week Low: 2.40p
  • Currency: UK Pounds
  • Shares Issued: 500.00m
  • Volume: 2,877,250
  • Market Cap: £16.00m
  • Beta: 0.17

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
02-Jan-25 Shore Capital House Stock 4.27p - - Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 3.20p
Change Today 0.050p
% Change 1.59 %
52 Week High 14.25p
52 Week Low 2.40p
Volume 2,877,250
Shares Issued 500.00m
Market Cap £16.00m
Beta 0.17

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.59% below the market average47.59% below the market average47.59% below the market average47.59% below the market average47.59% below the market average
4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average
Price Trend
88.69% below the market average88.69% below the market average88.69% below the market average88.69% below the market average88.69% below the market average
65.22% below the sector average65.22% below the sector average65.22% below the sector average65.22% below the sector average65.22% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 30-May-2025

Time Volume / Share Price
16:04 7,104 @ 3.14p
13:46 58,641 @ 3.24p
13:23 2,682 @ 3.12p
13:17 9,365 @ 3.12p
13:11 4,221 @ 3.27p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page